Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
| Revenue (TTM) | $720.06M |
| Gross Profit (TTM) | $608.75M |
| EBITDA | $95.69M |
| Operating Margin | 19.00% |
| Return on Equity | 30.40% |
| Return on Assets | 7.70% |
| Revenue/Share (TTM) | $9.13 |
| Book Value | $4.29 |
| Price-to-Book | 20.74 |
| Price-to-Sales (TTM) | 9.85 |
| EV/Revenue | 9.38 |
| EV/EBITDA | 68.67 |
| Quarterly Earnings Growth (YoY) | -68.40% |
| Quarterly Revenue Growth (YoY) | 53.00% |
| Shares Outstanding | $62.47M |
| Float | $49.52M |
| % Insiders | 5.08% |
| % Institutions | 95.07% |
Volatility is currently expanding
HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
Investors need to pay close attention to HNGE stock based on the movements in the options market lately.
IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
Hinge Health's Q2 revenues jump 53% as stronger member yield, margin gains and raised 2026 guidance reinforce business momentum.
Hinge Health NYSE: HNGE reported second-quarter 2026 revenue of $213 million, up 53% from a year earlier and above the company's prior guidance range of $200 million to $202 million. The digital healthcare company also raised its full-year revenue and operating-income outlook, citing durable improvements in member engagement, or yield, alongside continued margin expansion.
Hinge Health, Inc. (HNGE) Q2 2026 Earnings Call Transcript
Hinge Health Inc. (HNGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HNGE and any ticker you trade — then tracks every position and per-strategy win rate.
